January 11-15, 2027 | San Francisco
2027 Participating Companies
Clinical-stage biotech advancing mRNA therapeutics with proprietary LNP, tLNP and immuno-enhancer platforms, including in vivo CAR-T, cancer vaccines, and programs in metabolic and autoimmune diseases.